150 related articles for article (PubMed ID: 31060672)
1. [Correlations of Melatonin and Glutathione Levels with Oxidative Stress Mechanism in Parkinson's Disease].
Wei HJ; DU M; Bai HY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Apr; 41(2):183-187. PubMed ID: 31060672
[TBL] [Abstract][Full Text] [Related]
2. Serum melatonin is an alternative index of Parkinson's disease severity.
Lin L; Du Y; Yuan S; Shen J; Lin X; Zheng Z
Brain Res; 2014 Feb; 1547():43-8. PubMed ID: 24384141
[TBL] [Abstract][Full Text] [Related]
3. [Study on changes of plasma levels of oxidative stress biomarkers and its relation with cognition function in patients with parkinson's disease].
Zhou H; Yuan Y; Qi Z; Tong Q; Zhang K
Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(41):3357-60. PubMed ID: 26812976
[TBL] [Abstract][Full Text] [Related]
4. Melatonin and dopamine serum level associations with motor, cognitive, and sleep dysfunctions in patients with Parkinson's disease: A cross-sectional research study.
Hadoush H; Lababneh T; Banihani SA; Al-Jarrah M; Jamous M
NeuroRehabilitation; 2020; 46(4):539-549. PubMed ID: 32538881
[TBL] [Abstract][Full Text] [Related]
5. Elevated Plasma Melatonin Levels Are Correlated With the Non-motor Symptoms in Parkinson's Disease: A Cross-Sectional Study.
Li L; Zhao Z; Ma J; Zheng J; Huang S; Hu S; Gu Q; Chen S
Front Neurosci; 2020; 14():505. PubMed ID: 32508583
[TBL] [Abstract][Full Text] [Related]
6. [Protective effect of melatonin on myocardial injury in severely- burned rats].
Han XH; Xu L
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Dec; 24(12):747-9. PubMed ID: 23168205
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma orexin-A concentrations are associated with the non-motor symptoms in Parkinson's disease patients.
Huang S; Zhao Z; Ma J; Hu S; Li L; Wang Z; Sun W; Shi X; Li M; Zheng J
Neurosci Lett; 2021 Jan; 741():135480. PubMed ID: 33161104
[TBL] [Abstract][Full Text] [Related]
8. Plasma α-synuclein predicts cognitive decline in Parkinson's disease.
Lin CH; Yang SY; Horng HE; Yang CC; Chieh JJ; Chen HH; Liu BH; Chiu MJ
J Neurol Neurosurg Psychiatry; 2017 Oct; 88(10):818-824. PubMed ID: 28550072
[TBL] [Abstract][Full Text] [Related]
9. Detection of melatonin and homocysteine simultaneously in ulcerative colitis.
Chen M; Mei Q; Xu J; Lu C; Fang H; Liu X
Clin Chim Acta; 2012 Jan; 413(1-2):30-3. PubMed ID: 21763296
[TBL] [Abstract][Full Text] [Related]
10. [Protective effect of melatonin against renal dysfunction following severe burn in rats].
Han XH; Wen GQ; Xu L
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):721-3. PubMed ID: 18093427
[TBL] [Abstract][Full Text] [Related]
11. Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson's disease.
Gökçe Çokal B; Yurtdaş M; Keskin Güler S; Güneş HN; Ataç Uçar C; Aytaç B; Durak ZE; Yoldaş TK; Durak İ; Çubukçu HC
Neurol Sci; 2017 Mar; 38(3):425-431. PubMed ID: 27900485
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics in Parkinson's disease patients with cognitive impairment and effects of cognitive impairment on sleep].
Gong Y; Xiong KP; Mao CJ; Huang JY; Hu WD; Han F; Chen R; Liu CF
Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2637-41. PubMed ID: 24360043
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of sleep disorders in patients with Parkinson's disease.
Mao ZJ; Liu CC; Ji SQ; Yang QM; Ye HX; Han HY; Xue Z
J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):100-104. PubMed ID: 28224427
[TBL] [Abstract][Full Text] [Related]
14. Increased Serum Cystatin C in Early Parkinson's Disease with Objective Sleep Disturbances.
Xiong KP; Dai YP; Chen J; Xu JM; Wang Y; Feng P; You SJ; Liu CF
Chin Med J (Engl); 2018 Apr; 131(8):907-911. PubMed ID: 29664049
[TBL] [Abstract][Full Text] [Related]
15. Alterations in nocturnal serum melatonin levels in humans with growth and aging.
Waldhauser F; Weiszenbacher G; Tatzer E; Gisinger B; Waldhauser M; Schemper M; Frisch H
J Clin Endocrinol Metab; 1988 Mar; 66(3):648-52. PubMed ID: 3350912
[TBL] [Abstract][Full Text] [Related]
16. [The reduced level of plasma melatonin in HFRS patients is correlated with disease severity and stage].
Ma Y; Tang K; Song C; Fan L; Zhang Y; Zhang C; Zhang Y; Jin B; Ma Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Nov; 34(11):1027-1031. PubMed ID: 30591112
[TBL] [Abstract][Full Text] [Related]
17. Effects of exercise induced oxidative stress on glutathione levels in Parkinson's disease on and off medication.
Elokda A; DiFrancisco-Donoghue J; Lamberg EM; Werner WG
J Neurol; 2010 Oct; 257(10):1648-53. PubMed ID: 20461398
[TBL] [Abstract][Full Text] [Related]
18. [Sleep problems and the association with the levels of 6-sulfatoxymelatonin in children with autism spectrum disorder].
Han PP; Zou MY; Yang XL; Liu XC; Liang S; Sun CH; Xia W; Wu LJ
Zhonghua Er Ke Za Zhi; 2017 Dec; 55(12):911-915. PubMed ID: 29262470
[No Abstract] [Full Text] [Related]
19. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.
Medeiros CA; Carvalhedo de Bruin PF; Lopes LA; Magalhães MC; de Lourdes Seabra M; de Bruin VM
J Neurol; 2007 Apr; 254(4):459-64. PubMed ID: 17404779
[TBL] [Abstract][Full Text] [Related]
20. [Effects of oxidative stress on cognitive impairment in first episode schizophrenia].
Wang YP; Zhang PF; Yuan XX; Liu YF; Li HH; Tao Q; Li X; Pang LJ; Song XQ
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(1):9-13. PubMed ID: 30641657
[No Abstract] [Full Text] [Related]
[Next] [New Search]
